Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | +0.85% |
|
+4.42% | -31.40% |
Jun. 05 | DarioHealth Appoints Steven Nelson as Chief Commercial Officer | MT |
Jun. 05 | DarioHealth Corp. Announces Management Changes | CI |
Summary
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-31.40% | 35.01M | C- | ||
-6.24% | 180B | C+ | ||
-6.08% | 98.89B | C | ||
-5.98% | 66.26B | A | ||
-9.35% | 44.61B | B- | ||
+8.34% | 44.02B | B- | ||
+9.79% | 40.12B | B+ | ||
+11.88% | 29.19B | B | ||
-8.38% | 23.64B | A- | ||
+14.32% | 23.41B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DRIO Stock
- Ratings DarioHealth Corp.